Riskpilot← Back to searchSign inGet full accessInnovatrek AB
ABActiveOrg 5590722905Barnängsgatan 21General medical practice activities · NACE 8621Est. 20160 employees
Revenue 2025
SEK 0
EBITDA margin
—
-10% vs 2024
Equity ratio
19.5%
Financial strength
Net profit 2025
SEK 8,7M
+146% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -159K | -10% |
| Net profit | SEK 8,7M | +146% |
| Total assets | SEK 64,9M | +44% |
| Equity | SEK 12,7M | +59% |
| Employees | 0 | — |
Legal name
Innovatrek AB
Org number
5590722905
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
10 augusti 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall äga och förvalta aktier i dotterbolag samt i intressebolag. Bolaget ska bedriva konsultverksamhet inom management och hälsovård. Bolaget skall även bidraga med riskkapital till nya idéer och uppfinningar samt bistå andra företag i kommersialiseringen av nya idéer och innovationer genom aktivt stöd och anskaffning av riskkapital och därmed förenlig verksamhet.
Address
Barnängsgatan 21
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −96 | −94 | −76 | −144 | −159 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −96 | −94 | −76 | −144 | −159 |
| Net financials | — | −95 | −589 | 650 | 954 |
| Profit before tax | 7 704 | 4 810 | 1 740 | 4 464 | 10 573 |
| Tax | −1 649 | −992 | −369 | −929 | −1 887 |
| Net profit | 6 055 | 3 818 | 1 371 | 3 535 | 8 686 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 16 236 | 31 702 | 33 660 | 45 015 | 64 929 |
| Equity | 6 350 | 5 068 | 6 439 | 7 974 | 12 659 |
| Long-term debt | 0 | 6 325 | 5 048 | 3 795 | 9 995 |
| Short-term debt | 9 886 | 20 309 | 21 577 | 31 458 | 42 275 |
| Total debt | 9 886 | 26 634 | 26 625 | 35 253 | 52 270 |
EBITDA margin
-15900000.0%
This company
15.8%
Market median
-100633011% vs market
20212025
Equity ratio
19.5%
This company
38.2%
Market median
-49% vs market
20212025
Return on equity
68.6%
This company
18.4%
Market median
+273% vs market
20212025
Net profit margin
868600000.0%
This company
8.1%
Market median
+10723456690% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
4.13×
This company
0.62×
Market median
-566% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AA Chief Executive Officer | Chief Executive Officer | 2022 |
LM Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Innovatrek AB 
Enköpingshälsan ABBoard members of Innovatrek AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anousheh Abar | Chief Executive Officer | 0 companies |
| Lars Mikael Karlsson | Audit | 0 companies |
| Puja Abar | Chairman | 0 companies |
| Mojgan Ghamari | Deputy Board Member | 0 companies |